Newsroom
The Bulgarian Drug Agency has announced reduced time periods for consideration of clinical trials on medicinal products for…
Comac Medical has the pleasure to inform that we will be participating in this year’s ERS International Congress…
LONDON, June 9, 2023 /PRNewswire/ — Comac Medical (Comac or the Company) announced today that funds advised by EdgeCap Partners (EdgeCap) acquired…
Some of the aspects which will be covered are: The changing spectrum of growth disorders – and the…
Comac Medical Scientific Team will take part in 25th Pharmacokinetics/Pharmacodynamics (PK/PD) Expert Meeting, Nauen (Germany), April 20th -22nd,…
We are excited to share that our Head of Biostatistics, Prof. Krassimir Kalinov, has recently contributed as an…
In 2022, Comac Medical celebrates its 25th anniversary. Established way back in 1997 by Dr. Milen Vrabevski in…
We are happy to share that Comac Medical has been assigned with conducting Phase 2 randomized, placebo-controlled GULLIVER-2…
No more news
No more news